Literature DB >> 3867235

Reduction in locomotor activity of arthritic rats as parameter for chronic pain: effect of morphine, acetylsalicylic acid and citalopram.

J J Larsen, J Arnt.   

Abstract

Arthritis was induced in rats by plantar injection of a suspension of killed mycobacteria in Viscoleo. Non-treated rats served as controls. The locomotor activities of the rats were measured weekly during the following four weeks. The exploratory activity was determined in the daytime in activity cages and spontaneous locomotor activity was measured during the night in the same cages. From one week to four weeks after treatment in one hind paw the arthritic rats showed significantly lower exploratory activity than the control rats, whereas the spontaneous locomotor activity in the arthritic rats was not significantly reduced. After treatment in two hind paws both activities were significantly smaller in the arthritic group than in the control group. The low exploratory activity level of the arthritic rats was not changed by acetylsalicylic acid but was significantly increased by morphine and citalopram in doses which did not influence the exploratory activity of the control rats. The results suggest that reduction of the locomotor activity of arthritic rats might be a reliable parameter for chronic pain.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3867235     DOI: 10.1111/j.1600-0773.1985.tb00056.x

Source DB:  PubMed          Journal:  Acta Pharmacol Toxicol (Copenh)        ISSN: 0001-6683


  9 in total

1.  Efficacy of various analgesics on shoulder function and rotator cuff tendon-to-bone healing in a rat (Rattus norvegicus) model.

Authors:  Adam C Caro; Jennica J Tucker; Sarah M Yannascoli; Andrew A Dunkman; Stephen J Thomas; Louis J Soslowsky
Journal:  J Am Assoc Lab Anim Sci       Date:  2014-03       Impact factor: 1.232

2.  Influence of social interaction on nociceptive-induced changes in locomotor activity in a mouse model of acute inflammatory pain: Use of novel thermal assays.

Authors:  Branden A Smeester; Jang-Hern Lee; Alvin J Beitz
Journal:  Brain Res Bull       Date:  2017-06-23       Impact factor: 4.077

Review 3.  Citalopram. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in depressive illness.

Authors:  R J Milne; K L Goa
Journal:  Drugs       Date:  1991-03       Impact factor: 9.546

4.  Therapeutic efficacy in experimental polyarthritis of viral-driven enkephalin overproduction in sensory neurons.

Authors:  J Braz; C Beaufour; A Coutaux; A L Epstein; F Cesselin; M Hamon; M Pohl
Journal:  J Neurosci       Date:  2001-10-15       Impact factor: 6.167

5.  The pharmacologic evaluation of locomotor activity versus inflammatory parameters in rat adjuvant arthritis.

Authors:  J L Selph; V M Boncek; F E Soroko; T M Harris; F R Cochran
Journal:  Agents Actions       Date:  1993

6.  Restoration of spontaneous exploratory behaviors with an intrathecal NMDA receptor antagonist or a PKC inhibitor in rats with acute pancreatitis.

Authors:  Liping Zhang; Xuan Zhang; Karin N Westlund
Journal:  Pharmacol Biochem Behav       Date:  2004-01       Impact factor: 3.533

7.  Spontaneous inflammatory pain model from a mouse line with N-ethyl-N-nitrosourea mutagenesis.

Authors:  Tsung-Chieh Chen; José Jiun-Shian Wu; Wei-Pang Chang; Ping-Ning Hsu; Sung-Tsang Hsieh; Bai-Chuang Shyu
Journal:  J Biomed Sci       Date:  2012-05-30       Impact factor: 8.410

8.  "Bedside-to-Bench" Behavioral Outcomes in Animal Models of Pain: Beyond the Evaluation of Reflexes.

Authors:  Enrique J Cobos; Enrique Portillo-Salido
Journal:  Curr Neuropharmacol       Date:  2013-12       Impact factor: 7.363

9.  Sustained pain-related depression of behavior: effects of intraplantar formalin and complete freund's adjuvant on intracranial self-stimulation (ICSS) and endogenous kappa opioid biomarkers in rats.

Authors:  Michael D Leitl; David N Potter; Kejun Cheng; Kenner C Rice; William A Carlezon; S Stevens Negus
Journal:  Mol Pain       Date:  2014-09-23       Impact factor: 3.395

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.